Eli Lilly's Mounjaro price increase in the UK: what actually changed and what to do next

You checked the price last year and it has jumped since, here is why

Picture this: you bookmarked a provider's Mounjaro page in early 2025, came back in September to order, and found the figure had changed sharply. You are not imagining it. Eli Lilly increased the UK list price of Mounjaro on 1 September 2025. The highest-dose pen, which had sat at around £122 on the manufacturer's list, moved to around £330, and you can see exactly how those figures break down on the Lilly Mounjaro price page. For context, the full story of what changed and when explains the mechanics in detail, but the short version is that Lilly's pre-2025 pricing was unusually low by global standards and the adjustment brought the UK in line with other markets.

Most private pharmacies and clinics pass the cost of goods through to patients, so a list-price jump of that size rippled through the market quickly. Some providers absorbed part of the increase; most did not. The practical impact on UK private patients was felt most by those on higher maintenance doses, where the absolute monthly figure is larger, and there are serious questions about whether that impact falls equally across different patient groups, which the analysis of Mounjaro price increase inequality examines in detail. If you are comparing providers now, bear in mind that published prices typically reflect one dose tier, the full cost across a titration course will vary.

The MHRA continues to monitor Mounjaro under the Black Triangle (▼) scheme, which means the medicine carries additional post-market surveillance obligations regardless of price changes. That regulatory status does not change what you pay, but it is a reminder that oversight of this medicine is active and ongoing.

What a headline monthly price for Mounjaro usually does not include

A price listed on a website for Mounjaro is almost always the cost of the pen at a single dose tier. Whether that is the whole story depends entirely on the provider. Some charge separately for the initial consultation; others roll it in. Prescription fees are occasionally listed as a line item. Delivery (especially next-working-day tracked delivery) is not always free. Aftercare, the ongoing clinical contact that matters most when side effects appear or a dose change is due, is handled differently at every service.

It is also worth understanding how titration affects cost. Mounjaro treatment starts at 2.5mg (a dose that exists to settle the body's response, not to deliver the full therapeutic effect) and most patients move through several dose steps before reaching their maintenance level. Each step typically costs more than the last. A provider whose advertised price covers only the 2.5mg pen may look cheaper in week one than a service that prices transparently at each level. The full breakdown of UK Mounjaro pricing by dose is worth reading before you commit to any service.

On the NHS side, the September 2025 price rise did feed into discussions about the Eli Lilly Mounjaro UK price increase and NHS affordability. The phased NHS rollout under NICE technology appraisal TA1026 (verified from NICE's published recommendations for tirzepatide) continues, but access remains tightly criteria-led. For most people, private treatment is still the realistic near-term route.

Where nume sits in this market, plainly stated

We are not the cheapest option and we decided that deliberately. After the Lilly price increase, we could have found ways to trim what comes with treatment in order to publish a lower figure. We chose not to. One price at each dose covers the clinical consultation, the prescription, the medicine, and next-working-day DPD delivery. Your pen arrives in a plain box with a tracking link on your phone, no subscription, no renewal without a fresh clinical review, no surprise charges.

Every consultation is read the same day by a real prescriber. Our clinical team, which you can learn about at our clinical oversight page, reviews each case personally. That matters more after the price rise, not less, because a service cutting costs to compete on price has to cut somewhere, and clinical time is usually the first thing to go. For what our service actually costs at each dose, current pricing is shown on the treatment page; we do not print per-pen prices in editorial copy.

You can verify us at any point on the GPhC register: our pharmacy registration number is 9012878, verifiable directly at pharmacyregulation.org. Worth checking for any online pharmacy you consider.

Why price is the wrong test for a prescription medicine

For a prescription-only medicine like Mounjaro, the cheapest listing often answers the wrong question. The right question is: who is reviewing your medical history, what happens when you have a side effect at 11pm on a Sunday, and where did the medicine in that pen actually come from? Those questions matter because the counterfeit supply chain for weight-loss pens is real. The MHRA has seized roughly 20 million doses of illegally traded weight-loss medicines worth around £45 million, and in October 2025 enforcement teams raided the first illicit UK manufacturing site producing fake tirzepatide pens. Fake pens have been found to contain insulin instead of tirzepatide, a potentially life-threatening substitution. You can report a suspect seller or an adverse reaction at the MHRA's Yellow Card service.

A seller offering Mounjaro without asking for a prescription and a clinical assessment is a red flag, not a bargain. Discount codes for prescription medicines from unverified sources are another. The price increase Eli Lilly implemented makes the temptation to find a cheaper route understandable, but the risk profile of that route has not changed. If you want to understand more about how the price landscape compares across providers, our Mounjaro price guide sets out the full picture. Speak to our prescribers if you are ready to start or switch.